Search results
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Zacks· 1 day agoBristol-Myers Squibb Company (BMY Quick QuoteBMY - Free Report) is scheduled to report first-quarter 2024 results on Apr 25, before market open. In the previously reported quarter, the company ...
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
Simply Wall St. via Yahoo Finance· 2 days agoLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is...
Hussman Strategic Advisors Inc. Buys New Stake in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 21 hours agoHussman Strategic Advisors Inc. bought a new stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities ...
780 Shares in Bristol-Myers Squibb (NYSE:BMY) Bought by Wetzel Investment Advisors Inc.
ETF DAILY NEWS· 24 hours agoWetzel Investment Advisors Inc. acquired a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
FDA requires changes to CAR-T cell therapy boxed warning (NYSE:BMY)
Seeking Alpha· 4 days agoThe FDA has mandated updates to safety information for CAR-T cell therapies due to a severe risk of...
FY2024 EPS Estimates for Bristol-Myers Squibb (NYSE:BMY) Reduced by William Blair
ETF DAILY NEWS· 5 days agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at William Blair lowered their FY2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a research note issued to ...
Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by J.W. Cole Advisors Inc.
ETF DAILY NEWS· 2 days agoJ.W. Cole Advisors Inc. boosted its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 9.5% in the 4th quarter, Holdings Channel reports. The firm owned 31,831 shares of the biopharmaceutical ...
Bristol-Myers Squibb (NYSE:BMY) Stock Price Up 0.4% on Analyst Upgrade
ETF DAILY NEWS· 2 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) shares shot up 0.4% during trading on Friday after Wells Fargo & Company raised their price target on the stock from $51.00 to $52.00. Wells ...
Biotechnology and Pharmaceuticals
The Wall Street Transcript· 5 days agoApril 18, 2024 Buy ($175) Companies covered: Novo Nordisk A/S ( NYSE:NVO ), Eli Lilly and Company ( NYSE:LLY ), Amgen Inc. ( NASDAQ:AMGN ), Merck & Company, Inc. ( NYSE:MRK ), Roche Holdings ...
